Annual Drug Patent Expirations for ANDROGEL Androgel is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. There are eleven patents protecting…
The post New patent expiration for Abbvie drug ANDROGEL appeared fir…
Annual Drug Patent Expirations for ANDROGEL Androgel is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. There are eleven patents protecting…
The post New patent expiration for Abbvie drug ANDROGEL appeared fir…
Annual Drug Patent Expirations for ZOLADEX Zoladex is a drug marketed by Tersera and is included in two NDAs. It is available from two suppliers. There are three patents protecting…
The post New patent expiration for Tersera drug ZOLADEX appeared first…
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent expiration for Gilead Sciences drug COMPLERA appeared fi…
New patent expiration for Gilead Sciences drug COMPLERA Read Post »
Annual Drug Patent Expirations for EDURANT Edurant is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Janssen Prods drug EDURANT appeared first o…
New patent expiration for Janssen Prods drug EDURANT Read Post »
Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent expiration for Viiv Hlthcare drug JULUCA appeared first on …
New patent expiration for Viiv Hlthcare drug JULUCA Read Post »
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Gilead Sciences drug ODEFSEY appeared first on…
New patent expiration for Gilead Sciences drug ODEFSEY Read Post »
Annual Drug Patent Expirations for ZYKADIA Zykadia is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…
The post New patent expiration for Novartis drug ZYKADIA appeared fir…
Annual Drug Patent Expirations for CARDIZEM+LA Cardizem La is a drug marketed by Bausch and is included in one NDA. It is available from two suppliers. There is one patent…
The post New patent expiration for Bausch drug CARDIZEM LA appeared first on Dr…
New patent expiration for Bausch drug CARDIZEM LA Read Post »
CARDIZEM LA (diltiazem hydrochloride) Bausch Patent: 6,923,984 Expiration: Feb 25, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of February 21, 2021 Read Post »